Souha S. Kanj

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 5.8K citations

Bacterial Resistance, Antimicrobial Drug Discovery, Antimicrobial Susceptibility +14

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 731 citations · Full text

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 676 citations

Single-arm Open-label Trial, Antifungal Agent, Antifungal Agents +4

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009

Víctor Rosenthal, Bijie Hu, Dennis G. Maki et al. · American Journal of Infection Control · 2011 · 513 citations

Healthcare-associated Infection, International Health, Data Summary +5

International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009

Víctor Rosenthal, Dennis G. Maki, Silom Jamulitrat et al. · American Journal of Infection Control · 2010 · 510 citations

Healthcare-associated Infection, Hospital Epidemiology, June 2009 +6